GSK Balance Sheet Health
Financial Health criteria checks 3/6
GSK has a total shareholder equity of £13.5B and total debt of £16.1B, which brings its debt-to-equity ratio to 119.4%. Its total assets and total liabilities are £58.0B and £44.6B respectively. GSK's EBIT is £6.9B making its interest coverage ratio 13.1. It has cash and short-term investments of £3.2B.
Key information
119.4%
Debt to equity ratio
UK£16.06b
Debt
| Interest coverage ratio | 13.1x |
| Cash | UK£3.21b |
| Equity | UK£13.45b |
| Total liabilities | UK£44.60b |
| Total assets | UK£58.05b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: GSK's short term assets (£17.3B) do not cover its short term liabilities (£21.5B).
Long Term Liabilities: GSK's short term assets (£17.3B) do not cover its long term liabilities (£23.1B).
Debt to Equity History and Analysis
Debt Level: GSK's net debt to equity ratio (95.5%) is considered high.
Reducing Debt: GSK's debt to equity ratio has reduced from 183% to 119.4% over the past 5 years.
Debt Coverage: GSK's debt is well covered by operating cash flow (46.2%).
Interest Coverage: GSK's interest payments on its debt are well covered by EBIT (13.1x coverage).